Health tech company R1 RCM to be taken private in $8.9 bln deal (updated)

R1 RCM

01/08/2024 13:06

(Adds details in paragraphs 2,3 and 4)
       Aug 1 (Reuters) - Healthcare technology company R1 RCM
 RCM.O  said on Thursday private-equity firms TowerBrook Capital
Partners and Clayton, Dubilier & Rice (CD&R) were taking it
private in a deal worth $8.9 billion, including debt.
    The PE firms will acquire remaining shares of R1 RCM that
TowerBrook does not currently own for $14.30 per share.
        Shares of R1 RCM rose 8.7% to $14 in premarket trading.
The company provides services for billing and revenue collection
to hospitals, physician groups and other healthcare
organizations. 
  
        The deal is expected to close by the end of this year.
TowerBrook and CD&R expect to fund the transaction with a
combination of debt and equity. 
  
        
  

 (Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))